Case File
efta-efta00676443DOJ Data Set 9OtherFrom: "Nicholas J. Pritzker"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00676443
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Nicholas J. Pritzker"
To: Jeffrey Epstein <[email protected]>
Subject: science
Date: Mon, 27 Jan 2014 16:52:12 +0000
Jeffrey: thanks for another amazing dinner. I hope to see you sometime when we can actually string two sentences
together.
I'm also sick to sending money to institutions to see them fail to follow through in an efficient manner (although so far the
Molecular Engineering program at UC seems to be brilliantly executed: Zimmer and his team, including the new Provost
who is a good friend and was head of Argonne are exceptional....for now). Have any ideas for setting up something that
could be truly effective long-term? One of my problems (among many) is that I'm ok at setting things up, but terrible at
follow-up and administration. For example, Clean Energy Trust seems to be doing great, and we have two younger
directors who have taken the lead, but I just have no patience for administrative details, and I know long term I inevitably
rely on others to maintain the vision and provide direction and oversight.
Let me know if you have any thoughts about this
In addition to the ones you know such as Tesla and Solar City which are now public, and Spacex, Deep Mind and Uber,
where non-insider investments are not being sought as far as I know, here are some of the companies that we have
invested in recently, all of which will be raising at least some additional capital before IPO or sale (god willing), although I
cannot speak to whatever the valuations will be at the time. My cousin Tom really doesn't like venture and wants to
control his investments. I don't mind others controlling, as long as we are following really smart people into deals,
especially when we can invest not through expensive funds but as co-investors: that has been working for us so far
www.ploom.com this vaporizer company is owned 15% by us, 25% by Japan Tobacco International. Really interesting
technology, huge rising market. They will be raising another, hopefully final round soon.
www.proterra.com the only viable electric bus company (for now): it's compelling, but dealing with governments
is
well, you know
Maybe looking for a couple million more in this round, within the next month, and there
may well be another although I hope it's at an increased valuation
www.aquion.com an amazing battery technology: low energy density, low cost, recyclable, non-toxic, non-volatile. But an
area that everyone is trying to break open. We are betting that this company is a survivor. Another round coming early
2015.
More to come: personally, I love this shit: bet on technologies that HAVE to change the world. It feels good, especially
when they actually make money!
What we really need to get a better handle on are long managers and hedge funds: I have little interest in this, but we
need to get better performance: my son in law will be overseeing our efforts in this area (I hope), although his inclination
is to index everything and look for alpha in directs. I have to believe that some people can earn their fees in the
market
you think?
Talk soon, thanks again. nick
EFTA00676443
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.